Cell Therapeutics (CTIC) shares resume trading 25% higher
Tweet Send to a FriendGet Alerts CTIC Hot Sheet
Trade CTIC Now!
Cell Therapeutics (Nasdaq: CTIC) shares resume trading 25 percent higher.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Chile regulators stopped build, imposed sanctions on Barrick Gold (ABX)
- Highway Holdings (HIHO) Halted Again on Circuit Breaker; Last Up 80%
- UPDATE: Cell Therapeutics (CTIC) on The Move
Create E-mail Alert Related Categories
Trading HaltsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Up)